Review
Open access
Sep 2026
ELN vs. IPSS-M in MDS/AML: Which Prognostic System Should Guide Clinical Decision-Making?
Simple Summary Myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) is a recently recognized overlap entity that exhibits biological and clinical features intermediate between myelodysplastic syndromes and acute myeloid leukemia. Its emergence has challenged the application of traditional prognostic systems develo...
M. Liga, Angeliki N. Georgopoulou, D. Tsokanas et al.
· Cancers · 0 citations